Roche’s combo lymphoma treatment wins U.S. FDA approval

The U.S. Food and Drug Administration on Monday granted earlier-than-expected approval to Roche Holding AG's antibody-drug conjugate Polivy for treatment of patients with advanced lymphoma. Reuters Health News

https://en.ojaghia.vet

Leave a Reply

Time limit is exhausted. Please reload CAPTCHA.